Edwards Lifesciences (NYSE:EW) today shared two-year results from a trial evaluating its Cordella pulmonary artery (PA) ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results